L-670,596 is a selective and orally active thromboxane A2/prostaglandin receptor antagonist; it inhibits arachidonic acid- and U-44069-induced bronchoconstriction in guinea pigs and suppresses U-44069-induced aggregation of human platelet-rich plasma.